Zignol, Matteo <br/><br/>
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.  [electronic resource] 

 -  The Lancet. Infectious diseases  10 2016 
 - 1185-1192 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(16)30190-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Infective Agents--therapeutic use<br/>Antitubercular Agents--therapeutic use<br/>Asia<br/>Fluoroquinolones--therapeutic use<br/>Humans<br/>Microbial Sensitivity Tests<br/>Mycobacterium tuberculosis--drug effects<br/>Population Surveillance<br/>Pyrazinamide--therapeutic use<br/>Retrospective Studies<br/>Rifampin--pharmacology<br/>South Africa<br/>Tuberculosis, Multidrug-Resistant--drug therapy<br/>Tuberculosis, Pulmonary--drug therapy